Keytruda shows promise in helping patients with ‘untreatable’ prostate cancer
Merck and Co. reported positive results from several studies this week involving its major immunotherapy drug, Keytruda.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Immunotherapy | Merck | Pharmaceuticals | Prostate Cancer | Study